Hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs.
1
Recent genomic studies have outlined a landscape of recurrent alterations within some subtypes of lymphoid cancer.
2
NHEJ defects lead to severe combined immunodeficiency (SCID) and lymphoid cancer predisposition in both mice and humans.
3
The strong dependence of certain lymphoid cancer cells on BAFF might be a point of vulnerability, which offers exciting new therapeutic possibilities.